IMCD acquires US speciality pharmaceutical ingredient distributor Mutchler
Acquisition supports IMCD’s strategy to become a leading global speciality chemicals distributor
IMCD, a leading distributor of speciality chemicals, pharmaceutical and food ingredients, has acquired Mutchler and Mutchler of Puerto Rico.
With a focus on the pharmaceutical market, Mutchler complements IMCD’s existing US operations.
Mutchler is a speciality pharmaceutical ingredient distributor in the US and Puerto Rico with offices in Harrington Park, New Jersey, and Puerto Rico. Mutchler is active in all US states and Puerto Rico and represents leading global pharmaceutical ingredient suppliers.
In 2015, Mutchler generated revenue of $28m and has approximately 30 employees.
Given the firm's asset light business model and long-term relationships with leading global suppliers, Mutchler is an excellent fit for IMCD, the firm said.
The acquisition supports the strategy of IMCD to become the leading global specialty chemicals distributor providing expertise and knowledge based formulation solutions to its customers.
Marcus Jordan, President of IMCD Holdings US, commented: ‘Following the acquisition of MF Cachat (now IMCD US) in June 2015, this is an important next step as it expands our US operations into the pharmaceutical market, a strategic sector for IMCD. Mutchler has a reputation as a leading pharmaceutical ingredient supplier and we very much look forward to working together to further develop our offering to both suppliers and customers.’
Dwight Mutchler, President of Mutchler, adds: ‘We are delighted to become part of IMCD as the alliance immediately propels Mutchler into the future with a larger and more specialised team and added technical know-how.’